← Leaderboards
Sheng Pan
Baylor College Of Medicine
$3,505,701
Attributed
$6,399,378
Total exposure
6
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $944.9K · FY2010–25$1M$750K$500K$250K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,399,378 · 6
By mechanism
R01$4,769,503 · 2
K25$612,023 · 1
R21$396,128 · 1
UH3$328,995 · 1
UH2$292,729 · 1
Top collaborators
- Ru Chen11 shared
- Teresa A Brentnall2 shared
Most similar at Baylor College Of Medicine
Same institution · by research overlap
- Ru Chen$6,444,812
- David John Tweardy$14,168,425
- Robert Shulman$22,095,118
- Adam Antebi$2,596,195
- Eric A Williams$516,240
Others in their field
Top investigators on “Proteomics”
- David Heimbrook · Leidos Biomedical Research, Inc.$318,825,229
- Stanley M Lemon · Univ Of North Carolina Chapel Hill$110,612,005
- Alan F Horwitz · University Of Virginia Charlottesville$73,668,592
- Gaetano T Montelione · Rutgers The St Univ Of Nj New Brunswick$70,176,616
- Rolf Apweiler · European Molecular Biology Laboratory$67,677,991
- Daniel Ernest Ford · Johns Hopkins University$67,257,868
Research focus
ProteomicsMalignant NeoplasmsSamplingTechnologyInvestigationCohortBloodMalignant Neoplasm Of PancreasDiagnosisPlasmaEarly DiagnosisClinical ResearchCancer PatientBaseCessation Of LifeCancer EtiologyProteinsTumor ProgressionMolecularInterestStagingDetectionDiagnosticLead
Grant awards (18)
Elucidating the role of gut microbiota in colitis-associated colorectal cancer$615,878
R01 · FY2025 · CA
BLOOD-BASED PROTEOMIC ASSAY FOR PANCREATIC CANCER DETECTION$328,995
UH3 · FY2025 · CA
Elucidating the role of gut microbiota in colitis-associated colorectal cancer$585,084
R01 · FY2024 · CA
BLOOD-BASED PROTEOMIC ASSAY FOR PANCREATIC CANCER DETECTION$292,729
UH2 · FY2024 · CA
Elucidating the role of gut microbiota in colitis-associated colorectal cancer$649,138
R01 · FY2023 · CA
Early detection of pancreatic cancer in diabetics$534,119
R01 · FY2018 · CA
Early detection of pancreatic cancer in diabetics$50,409
R01 · FY2018 · CA
Early detection of pancreatic cancer in diabetics$587,611
R01 · FY2017 · CA
Early detection of pancreatic cancer in diabetics$574,199
R01 · FY2016 · CA
Early detection of pancreatic cancer in diabetics$572,954
R01 · FY2015 · CA
Early detection of pancreatic cancer in diabetics$600,111
R01 · FY2014 · CA
Quantitative glycoproteomics for pancreatic cancer studies$123,122
K25 · FY2014 · CA · contact PI
Quantitative glycoproteomics for pancreatic cancer studies$123,122
K25 · FY2013 · CA · contact PI
Aberrant Glycosylation Signature in Pancreatic Cancer$208,128
R21 · FY2012 · CA · contact PI
Quantitative glycoproteomics for pancreatic cancer studies$123,122
K25 · FY2012 · CA · contact PI
Aberrant Glycosylation Signature in Pancreatic Cancer$188,000
R21 · FY2011 · CA · contact PI
Quantitative glycoproteomics for pancreatic cancer studies$123,122
K25 · FY2011 · CA · contact PI
Quantitative glycoproteomics for pancreatic cancer studies$119,535
K25 · FY2010 · CA · contact PI